Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9603 posts found.

Vasella targeted by animal rights activists

August 6, 2009 Research and Development, Sales and Marketing Animal tests, Novartis, Vasella

Animal rights activists are believed to be behind two attacks on Novartis chief executive Daniel Vasella. The first attack came …
News

Afinitor approved in EU

August 6, 2009 Research and Development, Sales and Marketing Afinitor, Cancer, Europe, Novartis

Novartis’ new kidney cancer drug Afinitor (everolimus) has been approved in the EU for use when products such as Sutent …
News

US approval for Onglyza

August 6, 2009 Research and Development, Sales and Marketing AZ, BMA, diabetes

Adult type II diabetes treatment Onglyza has been approved by the US Food and Drug Administration. Co-marketed by AstraZeneca and …
News

Kennedy and Drayson: parallel plans to boost UK’s innovation agenda

August 5, 2009 Research and Development NICE, healthcare

1: The Office of Life Science’s ‘Blueprint’The first to be launched was the ‘Blueprint’ – a new strategic vision aiming …
Feature

Joint US-European clinical inspections launched

August 5, 2009 Research and Development Europe, US

News

Boehringer’s lung cancer candidate enters phase III

August 5, 2009 Research and Development, Sales and Marketing Boehringer, Cancer

Boehringer Ingelheim is to enter phase III studies with a candidate to treat a subset of patients with non-small cell …
News

ICR conference moves to London

August 4, 2009 Business Services, Research and Development Conference, ICR

The Institute of Clinical Research (ICR) is to hold its next annual spring conference and exhibition on 19-20 April at …
News

Covance lifted by $145m Merck deal

August 4, 2009 Research and Development CRO, Covance

Covance's late-stage development services unit helped the contract research organisation to a 7% increase in second quarter net revenues, ahead …
News

Avastin gets US approval in kidney cancer

August 4, 2009 Research and Development, Sales and Marketing Roche, US, avastin

Roche's rising star Avastin has won US approval to treat the most common type of kidney cancer, the latest in …
News

UCB in ‘dynamic mode’ as work begins at new biologics research centre

July 31, 2009 Research and Development UCB, biologics

 UCB has opened its new biologics research centre in the UK, marking an investment of £25 million for the growing …
Feature

Reshuffle at the top as Mylan deals with quality queries

July 31, 2009 Manufacturing and Production, Research and Development Mylan

US pharmaceutical firm Mylan has promoted chief operating officer Heather Bresch to the post of president as it rides a …
News

Merck Serono asks EMEA to re-think Erbitux rejection

July 30, 2009 Research and Development, Sales and Marketing Cancer, EMEA, Erbitux, Europe, Merck Serono

Merck Serono is to appeal against the European rejection of Erbitux as a lung cancer treatment.Erbitux has been rejected as …
News

Synexus expands

July 30, 2009 Research and Development CRO, Synexus

CRO Synexus has doubled its head office capacity as it continues to grow across the UK, Central and Eastern Europe, …
News

Contract research news in brief

July 28, 2009 Research and Development CRO

The first crop of second-quarter figures from the contract research sector reveals a mixed bag, with PPD and Icon affected …
News

Pharma and diagnostics to converge in personalised medicines

July 28, 2009 Research and Development, Sales and Marketing Diagnostics, strategy

News
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026